Member Info for Adyan9200

I noticed lightlife on Amazon, the product sold by is "RK World Infocom Pvt Ltd", you have to click "Other Sellers" to see the one sold by Dr Morepen directly as their listing is a few rupees higher. I'm surprised they have a third party selling it on Amazon.

Thanks AquaeSulis01 for the reply. It's not something I had considered would have been the reason for lack of commercialisation. Even if not within 10%, I would have thought some premium higher priced products would have been able to contain it at least to distinguish themselves from the competition etc.

Disappointing sums it up for me. The only decent news is they actually provided some information about Sweetbiotix, which they haven't for a while.

I really hoped that the first generation products this year would help us at least reach break-even, but looking at our outgoings, unless we have a stellar 2nd half, I can't see that happening. They mention "to deliver future revenue growth with the aim of achieving profitability across all parts of the business and the Group generating positive cashflow" but don't mention when they expect to reach this milestone.

Good to hear "Discovery of a new enzyme for SweetBiotix which has substantially higher yields which will significantly improve manufacturing costs.". However is this going to delay Sweetbiotix commercialisation further or was the initial cost what was preventing it and this new enzyme will help overcome that obstacle.

@AquaeSulis01 - Where did you hear about Firmenich not being able to scale-up at decent price (within 10% of sugar rpice) being the reason for the delay in Sweetbiotix being commercialised? I hadn't heard that before.

Some good news but still so much more to do.

5 Tons is a good start, I think it's something like 5000 x £30, so might be worth around £150k to OPTI. As this company is the USA no 1, I really hope they have the same success as Nouri FeelFull. I don't think any forecast has been provided of how much they expect to order this year, so hopefully 5 tons is just a starter and if they do well, we should get more orders soon. I assume we will have the warehouse setup and stocked in the USA to respond quickly to any demand.

I know back in 18 February 2025 RNS, "Nouri forecast a requirement for ten metric tons of SlimBiome in year one", but we know they were selling really well and had ordered more ahead of expectations I think.

As always it'll be Sweetbiotox that would be the game changer, but still no news on that end.

I believe AquaeSulis01 comment is on the right track.

I do believe we're not going to hear any direct numbers or even a vague number until the products by clients are on the shelf at the earliest. At the moment no product containing Zenakine is available yet.

Thanks hamcutlet for the link.

Good to hear that all round we are getting more demand than originally thought. I believe SOH was trying to say some of the Ingredient we're manufacturing in April/May might not appear in the H1 financial results as when they can show it in the accounts will vary, which is fair enough.

The selling to Morepen obviously is more profitable to us as we make money on the ingredient and the final product we make for them, so good to hear they are ordering more.

I'm hoping the recently announced deal between USA/UK helps with the Tariff issue, as it should be a straight-forward 10% now.

I'm still don't understand the need to have sold additional SBTX shares recently, as I would have thought the fund raise last year and the selling of SBTX over last 6 months would have been enough.

I am very much against this action, we are finally making solid progress, and with the re-ordering well ahead of schedule and doubling of order from US partner etc, all points to us getting to profitability much sooner than we expected earlier in the year. Plus SOH had already cut costs over last 2 years, therefore any further cuts are likely to be detrimental to us, unless there is something obvious to cut that won't need replacing.

Having a quiet word with SOH is the way to go, but I don't want TW destabilising the progress we are making.

T

That is excellent news. I'm happy they will be launching in H1 2025, so we should get more news in the next couple of months or so.

Things I noted:

1. We are supplying just the ingredient rather than making finished products for them (which would have been more profitable for us like the Morepen deal).

2. Opti have been working with this brand for past 18 months, including doing human studies so claims can be made in USA.

3. This news is considered material enough to require OPTI to release an RNS. So a very big client with possible future big orders, as it's early days I'm not expecting too much yet, but if it becomes a success like the Daily Nouri FeelFull, then it could become a great revenue earner. I think we will need to wait until year-end to see how it performs.

4. Slimbiome in Tablet form. This has come into my mind in the past, so good to see a client wanting this.

Does anyone have any ideas why OPTI have been selling SBTX shares again in March? As I had hoped he had finished with that and would leave the 9.58% we owed alone.

I was worried why SOH seems to be raising more cash by selling SBTX but have come to the conclusion that it may be to do with stocking up for our new USA clients.

"As we grow our sales in the USA we will need to warehouse stock and set up a USA subsidiary to support the short lead times required by retailers and ecommerce partners."

I thought I would take a bit of time before commenting.

1. The product is excellent. I believe some people panicked when anti-aging and other claims we had been led to believe were not mentioned in yesterday's RNS, whereas today's RNS does mention it. I can understand Croda wanting to concentrate on sleep, anxiety aspects of the product, as just anti-aging on it's own doesn't make you stand out in such a crowded market.

2. I'm surprised so many people are expecting SA to mentioned forecast or croda revenues when he's made it clear previously that he will not yet. I, like most others here do believe this action will hold us back and are desperate, even just something like we have received a 6/7 figure royalty payment already. But I was not expecting him to say anying around the royalties.

3. I think as always with Aim we had a lot of short term traders who decided to exit as no revenue figures announced.

4. On Aim in the past years getting an agreement with big companies used to be enough to drive the SP up, but because of so many failures by other companies and SBTX in past, that is no longer the case. Shareholders and market want to see figures.

My hope is SA does announce some royalty figures before end of June, as we do not want to wait until September or such.

I sold out my main PBX holding last week (I still have some in accounts that don't trade on Aquiss) as price increased, main reasons:

1. I have zero confidence in the Board and Steen to do what is in the best interest of shareholders.

2. I can see any increase in revenue will most likely get eaten by the increase number of employees.

3. Seed seems to be driving the vast majority of growth. There hasn't been any new clients really providing any new revenue.

4. From past experience, when Board and CEO don't take shareholders into consideration when making decisions, and don't give a valid reason for a massive dilution, they generally end up failing. I still think Probiotix can succeed and succeed very well, but as I have zero confidence in them, I just don't trust the Board and CEO to make the right decisions.

I've put the money raised by selling PBX into SBTX, as I have a lot more confidence there than here.

As I have shares in OPTI, I can still benefit indirectly if PBX do succeed.

The options have always been there. The previous options where at 8p which he didn't use, therefore the same number of options but at a higher price of 16p is better than it being at 8p again.

I'm just a little confused why anyone has a problem with people arranging interviews with CEOs of public listed companies etc even if it's behind a paywall. Financial times is behind a paywall, yet I don't see anyone complaining. As AIM companies get very little coverage as most investment publications etc only cover the larger companies, therefore every little helps and therefore anyone putting the effort to get clarifications around RNS, interviews etc should be applauded. There's so many AIM companies (or small companies) out there were we don't know what's happening, rumours all over the place, that I wish we had more people trying to get clarifications around RNS, get interviews and general information out of these companies as small investor we're not privy to what the bigger investors/stakeholders might know, even if they put that behind a paywall.

There's a massive gap in this area for AIM companies (and small companies in general), and for people to complain about others who try to fill this gap really are being unreasonable. There's nothing stopping themselves to do similar and make it freely available if they want (rather than complaining).

Also CEOs should be going around and promoting their companies and sharing what they do, where they are etc by doing interviews etc with publications etc, some of which have massive followings, and can only benefit existing share-holders. I wish more CEOs would do that.

Farris - I totally agree. With the information we currently have, I'm much more optimistic regarding SBTX than I am with OPTI. Not only that, Stuart has things moving in the other pillars which could all be very lucrative.

Only a couple of months ago OPTI was looking very bad, we didn't even know if Morepen was going ahead or whether it was one of those dozens of contracts we sign that go nowhere. But with things moving along there, I'm more optimistic now that OPTI at least will start to become profitable if the targets are achieved. We still don't know what's happening with Sweetbiotix, as we were expecting regular commercial launches throughout the year, but instead we seemed to have got pin silence. I'm really hopinh we hear of some solid progress in that area very soon.

Nice post Dustbin101.

I believe both OPTI and SBTX have finally reached an inflection point, and hopefully the only way is up. I do feel the pain some of the LTH of SBTX feel, as I am in the same position with OPTI where my average is much higher.

As an OPTI holder as well, I'm a little disappointed that OPTI has been selling SBTX shares, because I truly believe in 6 months time SBTX share price would be much much higher than today which would also have benefited OPTI holders and it's share price. Some people have mentioned OPTI sold to raise funds to pay the Morepen ingredients invoices etc, however I would have thought the fund raise they did earlier in the year would have covered that. It'll be nice to hear the raise was for a Sweetbiotix deal instead.

The thing that has helped the OPTI share price over last couple of weeks, is that we are seeing the Morepen deal materialize, in that we can see Morepen starting to advertise it via Social Media, we can see what the product looks like and Morepen CEO himself talking about it and the expected revenue they are targeting. We're no longer just relying on what OPTI are saying themselves.

Therefore I believe the SBTX share will get a boost once we start getting closer to the official launch, and Croda start releasing leaflets, information etc about the new ingredient. This will provide the wider market information on what Croda is saying this ingredient is capable of.

We should then get further boost on Launch day onwards, esp as we start seeing products being launched. If just 1 big name brand launches soon after, that'll increase the excitement further.

I do believe the share price will be at multiples than what we are currently at by the time we get to June.

In the interview he mentioned they anticipate 30-35 Crore for year 1.

I just hope OPTI can keep up with demand, my worry would be the situation we see sometimes where OPTI products are out of stock and it can take them months to get them back in stock. Therefore OPTI need to really be on top of their game, and if demand where to exceed anticipated sales, that they are nimble and able to react quickly.

Maybe that is why OPTI are selling SBTX shares so they have the funds and can react quickly, or it may be they are looking to fill a order for one of the other products (hopefully Sweetbiotix).

Almost 300k likes on that Instagram post, imagine how many views.

I agree AquaeSulis01. I think this Morepen launch is a lot bigger, more organised and making much better use of social media. Looking at the celebrities they are using such as Farah Khan, who is a very successful Director/Producer and well know there, and who has a much more average body shape for the target market (rather than using someone already very slim etc) I think is great marketing and convey this as a genuine product that works rather than a gimmick.

That's it's already had 100K likes (imagine how many views).

I'm so much more optimistic on this launch and Morepen being able to meet the target's than I have been with any other of OPTI's clients. I know some shareholders aren't happy with OPTI contributing to the Marketing budget, but I do believe it will prove to be worth every penny (esp most of the money OPTI will contribute will be only if Morepen meet the targets).

Now all we need is some good news on the Sweetbiotix front.

Wow, 1,236,972 @ 200.46k and the share price barely moved.